Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Inflamm Bowel Dis. 2011 Oct 21;18(7):1267–1274. doi: 10.1002/ibd.21908

Table 3.

Mean (standard error of the mean) pStat6 and pStat3 Scoring by Tumor Characteristics

Stat6 Stat3
N Epithelial Cell Immune Cell Epithelial Cell Immune Cell
TUMOR SITE ALL SITES 16 0.03(0.03) 0.09(0.04) 0.77(0.015) 1.06(0.16)
LEFT COLON 9 0.00(0) 0.08(0.04) 0.66(0.21) 1.17(0.22)
RIGHT COLON 6 0.08(0.08) 0.11(0.08) 0.96(0.26) 1.07(0.21)
TRANSVERSE COLON 1 0.00(0) 0.00(0) 0.67(0) 0.00(0)
HISTOLOGIC GRADE LOW GRADE 9 0.00(0) 0.10(0.04) 0.70(0.20) 1.27(0.16)*
HIGH GRADE 7 0.07(0.07) 0.07(0.07) 0.87(0.24) 0.78(0.27)
HISTOLOGIC TYPE ADENOCARCINOMA 10 0.05(0.05) 0.12(0.06) 0.75(0.19) 1.07(0.21)
MUCINOUS (COLLOID) 6 0.00(0) 0.03(0) 0.82(0.28) 1.04(0.25)
LYMPHNODES METASTASES 6 0.00(0) 0.00(0) 1.05(0.22) 1.21(0.16)**
NO METASTASES 10 0.05(0.05) 0.14(0.05) 0.61(0.19) 0.97(0.24)
IBD DIAGNOSIS CROHN’S DISEASE 2 0.00(0) 0.01(0.01) 0.00(0) 0.67(0.67)
ULCERATIVE COLITIS 14 0.04(0.04) 0.09(0.04) 0.89(0.15) 1.11(0.16)***
*

p<0.05 pStat3 immune cells low versus high grade

**

p<0.05 pStat3 immune cells lymph node metastases versus no lymph node metastases

***

p<0.05 pStat3 immune cells Crohn’s disease versus ulcerative colitis